THIS IS A DEVELOPMENT VERSION OF PROFILES. PLEASE GO TO THE PRODUCTION ENVIRONMENT FOR UPDATES

Header Logo

Connection

Michael Megaly to Risk Factors

Back to Details
This is a "connection" page, showing publications Michael Megaly has written about Risk Factors.
Michael Megaly
Connection Strength
3.680
Risk Factors
  1. Outcomes of Chronic Total Occlusion Percutaneous Coronary Intervention of the Left Anterior Descending Artery. Am J Cardiol. 2023 04 15; 193:75-82.
    View in: PubMed
    Score: 0.144
  2. Utilization of Non-Drug-Eluting Devices for Inpatient Percutaneous Coronary Intervention in the United States. Am J Cardiol. 2023 01 01; 186:209-215.
    View in: PubMed
    Score: 0.141
  3. Extraplaque versus intraplaque tracking in chronic total occlusion percutaneous coronary intervention. Catheter Cardiovasc Interv. 2022 11; 100(6):1021-1029.
    View in: PubMed
    Score: 0.140
  4. Comparative Analysis of Patient Characteristics in Chronic Total Occlusion Revascularization Studies: Trials vs Real-World Registries. JACC Cardiovasc Interv. 2022 07 25; 15(14):1441-1449.
    View in: PubMed
    Score: 0.138
  5. Trends and Outcomes of Myocardial Infarction in Patients With Previous Coronary Artery Bypass Surgery. Am J Cardiol. 2022 09 15; 179:11-17.
    View in: PubMed
    Score: 0.138
  6. "Power Carlino": A Novel Method for Modifying Wire-Impenetrable Proximal Caps During Chronic Total Occlusion Revascularization. JACC Cardiovasc Interv. 2021 11 22; 14(22):2521-2522.
    View in: PubMed
    Score: 0.131
  7. Outcomes of successful vs. failed contemporary chronic total occlusion percutaneous coronary intervention. Cardiovasc Interv Ther. 2022 Jul; 37(3):483-489.
    View in: PubMed
    Score: 0.131
  8. Diabetic Patients Who Present With ST-Elevation Myocardial Infarction. Cardiovasc Revasc Med. 2022 05; 38:89-93.
    View in: PubMed
    Score: 0.129
  9. Trends and Outcomes of Uilization of Thrombectomy During Primary Percutaneous Coronary Intervention. Cardiovasc Revasc Med. 2022 03; 36:83-88.
    View in: PubMed
    Score: 0.127
  10. Outcomes With Drug-Coated Balloons vs. Drug-Eluting Stents in Small-Vessel Coronary Artery Disease. Cardiovasc Revasc Med. 2022 02; 35:76-82.
    View in: PubMed
    Score: 0.126
  11. Ischemic Stroke With Cerebral Protection System During Transcatheter Aortic Valve Replacement. JACC Cardiovasc Interv. 2020 09 28; 13(18):2149-2155.
    View in: PubMed
    Score: 0.122
  12. Use of Intravascular Imaging in Patients With ST-Segment Elevation Acute Myocardial Infarction. Cardiovasc Revasc Med. 2021 09; 30:59-64.
    View in: PubMed
    Score: 0.121
  13. Risk Factors for the Development of Carotid Artery In-Stent Restenosis: Multivariable Analysis. Cardiovasc Revasc Med. 2021 03; 24:65-69.
    View in: PubMed
    Score: 0.121
  14. Retrograde Approach to Chronic Total Occlusion Percutaneous Coronary Intervention. Circ Cardiovasc Interv. 2020 05; 13(5):e008900.
    View in: PubMed
    Score: 0.118
  15. Outcomes of Chronic Total?Occlusion Percutaneous Coronary Intervention in Patients With Prior Bypass Surgery. JACC Cardiovasc Interv. 2020 04 13; 13(7):900-902.
    View in: PubMed
    Score: 0.117
  16. Short- and Long-Term Outcomes in Patients With New-Onset Persistent Left Bundle Branch Block After Transcatheter Aortic Valve Replacement. Cardiovasc Revasc Med. 2020 10; 21(10):1299-1304.
    View in: PubMed
    Score: 0.117
  17. Outcomes with retrograde versus antegrade chronic total occlusion revascularization. Catheter Cardiovasc Interv. 2020 11; 96(5):1037-1043.
    View in: PubMed
    Score: 0.115
  18. Outcomes With Deferred Versus Performed Revascularization of Coronary Lesions With Gray-Zone Fractional Flow Reserve Values. Circ Cardiovasc Interv. 2019 12; 12(12):e008315.
    View in: PubMed
    Score: 0.115
  19. Radial Versus Femoral Access in Chronic Total Occlusion Percutaneous Coronary Intervention. Circ Cardiovasc Interv. 2019 06; 12(6):e007778.
    View in: PubMed
    Score: 0.111
  20. Outcomes with cilostazol after endovascular therapy of peripheral artery disease. Vasc Med. 2019 08; 24(4):313-323.
    View in: PubMed
    Score: 0.110
  21. Outcomes with Drug-Coated Balloons in Percutaneous Coronary Intervention in Diabetic Patients. Cardiovasc Revasc Med. 2020 01; 21(1):78-85.
    View in: PubMed
    Score: 0.109
  22. Outcomes with drug-coated balloons in small-vessel coronary artery disease. Catheter Cardiovasc Interv. 2019 04 01; 93(5):E277-E286.
    View in: PubMed
    Score: 0.107
  23. Outcomes With Malignancy-Associated High-Risk Pulmonary Embolism: A Nationwide Analysis. Mayo Clin Proc. 2024 Jan; 99(1):81-89.
    View in: PubMed
    Score: 0.037
  24. Outcomes of Chronic Total Occlusion Percutaneous Coronary Interventions in Patients With Previous Coronary Artery Bypass Graft Surgery. Am J Cardiol. 2023 10 15; 205:40-49.
    View in: PubMed
    Score: 0.037
  25. Meta-Analysis on Transcarotid Versus Transfemoral and Other Alternate Accesses for Transcatheter Aortic Valve Implantation. Am J Cardiol. 2023 04 01; 192:196-205.
    View in: PubMed
    Score: 0.036
  26. Impact of proximal cap ambiguity on the procedural techniques and outcomes of chronic total occlusion percutaneous coronary intervention: Insights from the PROGRESS-CTO Registry. Catheter Cardiovasc Interv. 2023 03; 101(4):737-746.
    View in: PubMed
    Score: 0.036
  27. External validation of the PROGRESS-CTO complication risk scores: Individual patient data pooled analysis of 3 registries. Int J Cardiol. 2023 03 15; 375:14-20.
    View in: PubMed
    Score: 0.035
  28. Use of Mechanical Circulatory Support in Chronic Total Occlusion Percutaneous Coronary Intervention. Am J Cardiol. 2023 02 15; 189:76-85.
    View in: PubMed
    Score: 0.035
  29. Gender differences in chronic total occlusion percutaneous coronary interventions: Insights from the PROGRESS-CTO registry. Catheter Cardiovasc Interv. 2022 11; 100(6):1010-1018.
    View in: PubMed
    Score: 0.035
  30. Sex Differences in Management and Outcomes Among Patients With High-Risk Pulmonary Embolism: A Nationwide Analysis. Mayo Clin Proc. 2022 10; 97(10):1872-1882.
    View in: PubMed
    Score: 0.035
  31. Contemporary National Trends and Outcomes of Pulmonary Embolism in the United States. Am J Cardiol. 2022 08 01; 176:132-138.
    View in: PubMed
    Score: 0.034
  32. Temporal Trends in Retrograde Crossing of Epicardial Collaterals in Chronic Total Occlusion Percutaneous Coronary Intervention. J Invasive Cardiol. 2022 04; 34(4):E294-E295.
    View in: PubMed
    Score: 0.034
  33. Update on chronic total occlusion percutaneous coronary intervention. Prog Cardiovasc Dis. 2021 Nov-Dec; 69:27-34.
    View in: PubMed
    Score: 0.033
  34. Impact of Hospital Procedural Volume on?Outcomes After Endovascular Revascularization for Critical Limb?Ischemia. JACC Cardiovasc Interv. 2021 09 13; 14(17):1926-1936.
    View in: PubMed
    Score: 0.032
  35. Meta-analysis comparing valve-in-valve TAVR and redo-SAVR in patients with degenerated bioprosthetic aortic valve. Catheter Cardiovasc Interv. 2021 11 01; 98(5):940-947.
    View in: PubMed
    Score: 0.032
  36. Coronary artery bypass grafting after acute ST-elevation myocardial infarction. J Thorac Cardiovasc Surg. 2023 02; 165(2):672-683.e10.
    View in: PubMed
    Score: 0.031
  37. Contemporary Revascularization Strategies and Outcomes Among Patients With Diabetes With Critical Limb Ischemia: Insights From the National Inpatient Sample. JACC Cardiovasc Interv. 2021 03 22; 14(6):664-674.
    View in: PubMed
    Score: 0.031
  38. Outcomes of Transcarotid Versus Trans-Subclavian Transcatheter Aortic Valve Replacement: A Systematic Review and Meta-Analysis. Cardiovasc Revasc Med. 2021 12; 33:20-25.
    View in: PubMed
    Score: 0.031
  39. Outcomes of transcatheter versus surgical aortic valve replacement among solid organ transplant recipients. Catheter Cardiovasc Interv. 2021 03; 97(4):691-698.
    View in: PubMed
    Score: 0.031
  40. Impact of adherence to the hybrid algorithm for initial crossing strategy selection in chronic total occlusion percutaneous coronary intervention. Rev Esp Cardiol (Engl Ed). 2021 Dec; 74(12):1023-1031.
    View in: PubMed
    Score: 0.031
  41. Temporal trends and outcomes of critical limb ischemia among patients with chronic kidney disease. Vasc Med. 2021 04; 26(2):155-163.
    View in: PubMed
    Score: 0.030
  42. Impact of Successful Chronic Total Occlusion Percutaneous Coronary Interventions on Subsequent Clinical Outcomes. J Invasive Cardiol. 2020 Nov; 32(11):433-439.
    View in: PubMed
    Score: 0.030
  43. Clinical Characteristics and Outcomes?of?STEMI Patients With Cardiogenic Shock and Cardiac Arrest. JACC Cardiovasc Interv. 2020 05 25; 13(10):1211-1219.
    View in: PubMed
    Score: 0.030
  44. Use of Radiation Protection Measures in Live Percutaneous Coronary Interventions Cases at Interventional Scientific Meetings. JACC Cardiovasc Interv. 2020 04 13; 13(7):905-906.
    View in: PubMed
    Score: 0.029
  45. Retrograde Chronic Total Occlusion Percutaneous Coronary Intervention via?Saphenous Vein Graft. JACC Cardiovasc Interv. 2020 02 24; 13(4):517-526.
    View in: PubMed
    Score: 0.029
  46. Temporal Trends and Outcomes of Transcatheter Mitral Valve Repair Among Nonagenarians. JACC Cardiovasc Interv. 2020 06 08; 13(11):1385-1387.
    View in: PubMed
    Score: 0.029
  47. Outcomes of subintimal plaque modification in chronic total occlusion percutaneous coronary intervention. Catheter Cardiovasc Interv. 2020 11; 96(5):1029-1035.
    View in: PubMed
    Score: 0.029
  48. Temporal Trends and Outcomes of Mechanical Complications in Patients With Acute?Myocardial Infarction. JACC Cardiovasc Interv. 2019 09 23; 12(18):1825-1836.
    View in: PubMed
    Score: 0.028
  49. In-Hospital Outcomes with Transfemoral Versus Transapical Access for Transcatheter Aortic Valve Replacement in Patients with Peripheral Arterial Disease. Cardiovasc Revasc Med. 2020 05; 21(5):604-609.
    View in: PubMed
    Score: 0.028
  50. Impact of diastolic dysfunction on long-term mortality and quality of life after transcatheter aortic valve replacement. Catheter Cardiovasc Interv. 2020 04 01; 95(5):1034-1041.
    View in: PubMed
    Score: 0.028
  51. Low-Risk Transcatheter Versus Surgical Aortic Valve Replacement - An Updated Meta-Analysis of Randomized Controlled Trials. Cardiovasc Revasc Med. 2020 04; 21(4):441-452.
    View in: PubMed
    Score: 0.028
  52. In-hospital outcomes of transcatheter versus surgical aortic valve replacement for nonagenarians. Catheter Cardiovasc Interv. 2019 04 01; 93(5):989-995.
    View in: PubMed
    Score: 0.027
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

THIS IS A DEVELOPMENT VERSION OF PROFILES. PLEASE GO TO THE PRODUCTION ENVIRONMENT FOR UPDATES